Identification of two cancer stem cell-like populations in triple-negative breast cancer xenografts

Dis Model Mech. 2022 Jun 1;15(6):dmm049538. doi: 10.1242/dmm.049538. Epub 2022 Jun 23.

Abstract

Gene expression analysis at the single-cell level by next-generation sequencing has revealed the existence of clonal dissemination and microheterogeneity in cancer metastasis. The current spatial analysis technologies can elucidate the heterogeneity of cell-cell interactions in situ. To reveal the regional and expressional heterogeneity in primary tumors and metastases, we performed transcriptomic analysis of microtissues dissected from a triple-negative breast cancer (TNBC) cell line MDA-MB-231 xenograft model with our automated tissue microdissection punching technology. This multiple-microtissue transcriptome analysis revealed three cancer cell-type clusters in the primary tumor and axillary lymph node metastasis, two of which were cancer stem cell (CSC)-like clusters (CD44/MYC-high, HMGA1-high). Reanalysis of public single-cell RNA-sequencing datasets confirmed that the two CSC-like populations existed in TNBC xenograft models and in TNBC patients. The diversity of these multiple CSC-like populations could cause differential anticancer drug resistance, increasing the difficulty of curing this cancer.

Keywords: Breast cancer; Cancer; Cancer stem cell; Spatial transcriptome; Xenograft model; scRNA-seq.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Cell Line, Tumor
  • Heterografts
  • Humans
  • Neoplastic Stem Cells / pathology
  • Triple Negative Breast Neoplasms* / drug therapy

Substances

  • Antineoplastic Agents